西酞普兰治疗肺癌术后抑郁症的临床观察 点击下载
论文标题: 西酞普兰治疗肺癌术后抑郁症的临床观察
英文标题:
中文摘要: 目的:观察西酞普兰治疗肺癌术后抑郁症的临床疗效及安全性。方法:选取肺癌术后伴发抑郁症的患者114例,按随机数字表法分为观察组和对照组,各57例。对照组患者术后给予营养支持、平衡电解质等常规治疗,未服用抗抑郁药物;观察组患者术后口服氢溴酸西酞普兰片20 mg,qd。两组患者均连续治疗6周。观察两组患者临床疗效及治疗前后汉密尔顿抑郁量表(HAMD)评分、汉密尔顿焦虑量表(HAMA)评分、健康调查量表(SF-36)评分,并记录不良反应发生情况。结果:观察组总有效率为87.72%,显著高于对照组的71.93%,差异有统计学意义(P<0.05);两组患者治疗前HAMD评分、HAMA评分及SF-36各项评分和总分比较,差异无统计学意义(P>0.05);两组患者治疗后HAMA评分、HAMD评分显著降低,且观察组显著低于对照组,SF-36各项评分和总分显著升高,且观察组显著高于对照组,差异均有统计学意义(P<0.05)。两组患者均未见明显不良反应发生。结论:西酞普兰治疗肺癌术后抑郁症的疗效显著,能明显改善患者精神状态和生存质量,且安全性较好。
英文摘要: OBJECTIVE: To observe clinical efficacy and safety of citalopram in the treatment of depression patients after lung cancer operation. METHODS: 114 depression patients after lung cancer operation were selected and randomly divided into observation group and control group (n=57). Control group was given routine treatment as nutrition support and electrolyte balance, but had no anti-depression drugs; observation group was given Citalopram tablet 20 mg orally, qd. Two groups were treated for 6 weeks. Clinical efficacy, HAMD and HAMA scores, each score and total score of SF-36 were observed before and after treatment. The occurrence of ADR was recorded. RESULTS: The total effective rate of observation group was 87.72%, which was significantly higher than that that of control group (71.93%), with statistical significance (P<0.05); there was no statistical significance in HAMA score, HAMD score, each score and total score of SF-36 between 2 groups before treatment (P>0.05); HAMA score and HAMD score of 2 groups decreased significantly after treatment, the observation group was lower than the control group; each score and total score of SF-36 increased significantly, the observation group was higher than the control group, with statistical significance (P<0.05). No obvious ADR was found in 2 groups. CONCLUSIONS: Citalopram is effective and safe for depression after lung cancer operation, can improve mental state and quality of life.
期刊: 2016年第27卷第17期
作者: 孙振卿,郭强,李鹤飞,王海波,祖金池,石林,张越,李亚静,桑文华
英文作者: SUN Zhenqing,GUO Qiang,LI Hefei,WANG Haibo,ZU Jinchi,SHI Lin,ZHANG Yue,LI Yajing,SANG Wenhua
关键字: 西酞普兰;抑郁症;安全性;肺癌
KEYWORDS: Citalopram; Depression; Safety; Lung cancer
总下载数: 81次
本日下载数: 2次
本月下载数: 81次
文件大小: 619.60Kb

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!